The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 11, 2018

Filed:

Jan. 14, 2015
Applicants:

Shin Nippon Biomedical Laboratories, Ltd., Kagoshima-shi, JP;

Wave Life Sciences Japan, Inc., Kagoshima-shi, JP;

Inventors:

Takefumi Gemba, Kagoshima, JP;

Ryoichi Nagata, Kagoshima, JP;

Yusuke Torikai, Kagoshima, JP;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/117 (2010.01); A61K 39/39 (2006.01); A61K 31/7088 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 31/7088 (2013.01); C12N 15/117 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/572 (2013.01); C12N 2310/17 (2013.01); C12N 2310/315 (2013.01); C12N 2310/344 (2013.01); C12N 2320/31 (2013.01);
Abstract

Summary Problem The purpose of the present invention is to provide: a chiral nucleic acid adjuvant having anti-tumor activity; and an anti-tumor agent. Solution The present invention relates to an adjuvant for anti-tumor agent, wherein the adjuvant comprises oligonucleotides which comprise two to four CpG motif each represented by 5'-XCpGX-3′ and has a length of 14 to 32 nucleotides, wherein a nucleic acid at 3′ end side of at least two CpG motifs is connected by phosphorothioate linkage, wherein each nucleic acid at 3′ end and 5′ end of the oligonucleotide is S type nucleic acid connected by phosphorothioate linkage, and wherein the oligonucleotide comprises at least one nucleic acid without phosphorothioate modification. The present invention relates to an anti-tumor agent containing its adjuvant.


Find Patent Forward Citations

Loading…